Public and Global Health
Showing page 21 of 214 pages of list content
-
Remdesivir in treatment of COVID-19: A systematic benefit-risk assessment
This article's authors -
The characteristics and death risk factors of 132 COVID-19 pneumonia patients with comorbidities: a retrospective single center analysis in Wuhan, China
This article's authors -
Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a dynamic framework for rapid decision-making
This article's authors -
Chloroquine and hydroxychloroquine effectiveness in human subjects during coronavirus: a systematic review
This article's authors -
YouTube as an information source during the Coronavirus disease (COVID-19) pandemic: Evaluation of the Turkish and English content
This article's authors -
Celebrex adjuvant therapy on COVID-19: An experimental study
This article's authors -
What factors increase the risk of complications in SARS-CoV-2 positive patients? A cohort study in a nationwide Israeli health organization
This article's authors -
How robust are the results of one of the first positive trials exploring hydroxychloroquine for treatment of COVID-19?
This article's authors -
A study on the relationship between BCG vaccination and Covid-19 prevalence: Do other confounders warrant investigation?
This article's authors -
The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing
This article's authors